Delivery Order SPE2D020D0005-SPE2D324F092Z

Award Date 7/3/24
Potential Completion Date 7/9/24
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,842.80 firm fixed-price delivery order contract to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, which runs through August 2024, is for the provision of 4565467121 ondansetron orally disintegrating tablets (ODT) 4 mg. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) with Chartwell RX, valued at over $7 million and running through March 2030,...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 8 mg ondansetron oral disintegrating tablets in 30-count packages, with a firm fixed price of $2,959.65 and a completion date of March 12, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
This is a delivery order awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,724.35 firm-fixed-price contract is for the delivery of ondansetron orally disintegrating tablets (ODT) 4 mg, with a completion date of July 25, 2024. Chartwell RX LLC is a for-profit organization registered in the System for Award Management (SAM) that specializes in providing a wide range of branded and generic...
This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of 30-count packages of 8 mg ondansetron orally disintegrating tablets. Awarded by the Defense Logistics Agency (DLA) Troop Support Medical, this $3,946.20 firm fixed price delivery order does not have a set-aside designation. It is part of a larger $7 million-plus single-award indefinite delivery vehicle (IDV) contract held by Chartwell with DLA Troop Support...
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order to Chartwell RX LLC, a for-profit organization, for the supply of ondansetron orally disintegrating tablets. The $1,302.95 order is part of Chartwell RX's broader contract vehicles with the Defense Logistics Agency and the Department of Veterans Affairs to provide pharmaceutical products to support military and veteran healthcare services. No set-asides were used for this specific delivery order, which...
The Defense Logistics Agency Troop Support Medical awarded a $1,895.20 firm fixed price delivery order to Chartwell RX LLC, a for-profit organization, to provide 4,563,150,434 units of Ondansetron Orally Disintegrating Tablets (ODT) 4 mg. The delivery order has a completion date of December 26, 2023 and was awarded on December 20, 2023. Chartwell RX LLC is an established pharmaceutical supplier to the federal government, holding contracts with the Department of Veterans Affairs and the Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract, valued at $3,553.50, is for the supply of Ondansetron ODT 4 mg tablets to the agency. This contract is part of a larger Indefinite Delivery Contract (SPE2D020D0005) with the DLA Troop Support Medical, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad...
This contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of ondansetron orally disintegrating tablets in 30-count packages. The $2,369.00 firm fixed-price delivery order was issued on November 8, 2024, with a completion date of November 14, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at over $7 million with the Defense Logistics Agency (DLA) Troop Support Medical, which allows...
  • SPE2D020D0005
    Indefinite Delivery Contract
  • SPE2D020D0005-SPE2D324F092Z
    Delivery Order

This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of medications to military treatment facilities worldwide. Chartwell RX has also secured other significant federal contracts, including a $139.7 million small business set-aside award for doxycycline and amoxicillin, as well as a Federal Supply Schedule contract with the Department of Veterans Affairs. The company's proven ability to meet diverse government healthcare supply needs has led to these multiple contract awards.

Generated 10/2/24, 10:59 AM